General
Oxford-AstraZeneca, local COVID vaccines given urgent approval in India
The head of India’s drugs regulator said he had given final approval for the emergency use of two coronavirus vaccines, one developed by AstraZeneca and Oxford University and the other by local company Bharat Biotech.
Key points:
- India’s pharmaceutical regulator approved two COVID-19 vaccines simultaneously
- The Australian Government has ordered 50 million doses of the Oxford-AstraZeneca vaccine
- India’s first round of vaccinations aims to immunise 300 million people against coronavirus
The overall efficacy of the Oxford-AstraZeneca vaccine was 70.42 per cent, while Bharat Biotech’s COVAXIN was “safe and provides a robust immune response”, Drugs Controller General of India, Venugopal G Somani, said.
The British-developed Oxford-AstraZeneca…
Continue Reading
